On Friday 4 October, Mr. Justice Arnold handed down his judgment in the long-running passing off saga concerning the colour of Sandoz’s AirFluSal Forspiro dry-powder inhaler for the treatment of asthma and COPD.

Bristows acted for Vectura, who was joined to the proceedings as co-defendants for its role in the development of the inhaler.

After a 14-day trial, Mr. Justice Arnold found in favour of Sandoz and Vectura and dismissed all of Glaxo’s allegations of passing off.

Please see a PDF summary of the High Court judgment in Glaxo Wellcome UK Ltd (t/a Allen & Hanburys) v Sandoz Ltd and Vectura.